Document is current
Any future updates will be listed below
-
Authors
Carai, Paolo
Ruozi, Giulia
Paye, Alexandra
Debing, Yannick
Bortolotti, Francesca
Lecomte, Julie
Zentilin, Lorena
Jones, Elizabeth A. V.
Giacca, Mauro
Heymans, Stephane
-
Funding
Funding for this research was provided by:
European Research Area Network on Cardiovascular Diseases,Germany (MacroERA, 01KL1706)
Fonds Wetenschappelijk Onderzoek (G091018N)
Netherlands Cardiovascular Research Initiative (CVON Arena-PRIME, 2017–18)
European Research Area Network on Cardiovascular Diseases (LYMIT-Dis)
- License Information
-
More Information
Article History
Received: 1 October 2021
Accepted: 31 March 2022
First Online: 4 May 2022
Competing interests
: M.G. is a founder, consultant, and equity holder in Purespring Therapeutics (London, UK), which owns the rights on the FunSel technology and AAV library. F.B. is a consultant in the same company. All remaining authors, P.C., G.R., A.P., Y.D., J.L., L.Z., E.A.V.J., and S.H., declare no competing interests.
